Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D001665:Binding Sites; D002462:Cell Membrane / Q000276:immunology; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003911:Dextrans / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli; D005455:Fluorescent Antibody Technique; D007934:Leuconostoc; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008934:Mitogens / Q000008:administration & dosage / Q000494:pharmacology*; D008970:Molecular Weight; D011135:Polysaccharides, Bacterial / Q000494:pharmacology; D013229:Stearic Acids; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D013464:Sulfuric Acids; D014316:Tritium
D003911:Dextrans; D008070:Lipopolysaccharides; D008934:Mitogens; D011135:Polysaccharides, Bacterial; D013229:Stearic Acids; D013464:Sulfuric Acids; D014316:Tritium; D003208:Concanavalin A; D004247:DNA